The impact of environmental contaminants, air pollution, and social deprivation on childhood leukemia survival in California. Read more about The impact of environmental contaminants, air pollution, and social deprivation on childhood leukemia survival in California.
Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY Trial. Read more about Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY Trial.
Utilization of dexrazoxane in patients treated with doxorubicin: a retrospective, propensity matched analysis of cardiac function and toxicity. Read more about Utilization of dexrazoxane in patients treated with doxorubicin: a retrospective, propensity matched analysis of cardiac function and toxicity.
Young lung cancer: from diagnosis to survivorship. Read more about Young lung cancer: from diagnosis to survivorship.
Toward standardized brain tumor tissue processing protocols in neuro-oncology: a perspective for gliomas and beyond. Read more about Toward standardized brain tumor tissue processing protocols in neuro-oncology: a perspective for gliomas and beyond.
Pragmatic clinical trials for localized prostate cancer: lessons learned and "three sins". Read more about Pragmatic clinical trials for localized prostate cancer: lessons learned and "three sins".
Comparison of 18F-DCFPyL and 68Ga-PSMA-11 for 177Lu-PSMA-617 therapy patient selection. Read more about Comparison of 18F-DCFPyL and 68Ga-PSMA-11 for 177Lu-PSMA-617 therapy patient selection.
Pulmonary hypertension in the intensive care unit after pediatric allogeneic hematopoietic stem cell transplant: incidence, risk factors, and outcomes. Read more about Pulmonary hypertension in the intensive care unit after pediatric allogeneic hematopoietic stem cell transplant: incidence, risk factors, and outcomes.
Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma. Read more about Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma.
Editorial: Biological aspects of bone marrow failure. Read more about Editorial: Biological aspects of bone marrow failure.
